GHRP-1

Fat LossGrowth hormone-releasing peptide / researchExperimental

GHRP-1 is a growth hormone-releasing peptide in the Growth Hormone Secretagogue class. GHRP-1 is a synthetic enkephalin-derived peptide that binds the growth hormone secretagogue receptor 1a on pituitary somatotrophs and hypothalamic neurons, the receptor for ghrelin. Activation stimulates pulsatile growth hormone release through a pathway distinct from and synergistic with growth hormone-releasing hormone.

Calculate Dose

For research use only.

Key Facts

CAS
141925-59-9
Molecular Weight (MW)
955.1 g/mol
Half-life
โ€”
FDA status
Not Approved
Administration Route
subcutaneous
Frequency
โ€”
Last updated
Aug 30, 2026
Reviewed
Aug 30, 2026

Research summary

Synthetic hexapeptide growth hormone secretagogue from the same series as GHRP-2 and GHRP-6. Not FDA-approved and less studied than either. Human pharmacokinetic data is limited.

Peptide Library's GHRP-1 profile summarises 5 cited studies listed in the Science section, the compound's regulatory status, and research-protocol parameters reported for it. It is a research reference, not medical advice.

Protocol

Dosage Range
โ€”
Frequency
โ€”
Cycle
โ€”
Administration Route
subcutaneous
Reconstitution Guide
โ€”

Sequence & molecular data

Sequence and molecular data for GHRP-1
Molecular formulaC51H62N12O7
Molecular weight955.1 g/mol
CAS number141925-59-9
PubChem CID10350910
FDA UNII39EVI31P0W
ChEMBLCHEMBL427926

Identifiers link to the public PubChem, FDA Substance Registration (UNII), ChEMBL and DrugBank records for the same entity.

Science

Mechanism of Action

GHRP-1 is a synthetic enkephalin-derived peptide that binds the growth hormone secretagogue receptor 1a on pituitary somatotrophs and hypothalamic neurons, the receptor for ghrelin. Activation stimulates pulsatile growth hormone release through a pathway distinct from and synergistic with growth hormone-releasing hormone. Selectivity for GH over cortisol and prolactin is lower than that of ipamorelin.

Regulatory & research status

GHRP-1 is not an FDA-approved product. It is sold for laboratory research and has no approved medical use.

Regulatory and research status for GHRP-1
FDA statusNot Approved
Research statusResearch-only compound; no approval pathway listed
AvailabilityResearch-Only
WADA (sport)Unknown / Not Listed
Library classificationResearch-Only

Benefits

โ€”

Potential Side Effects

No side effects listed yet for this entry.

Storage & stability

Lyophilized (freeze-dried) peptide powder is far more stable than the reconstituted solution. Keep sealed vials cold, dry and away from light; long-term storage is typically frozen, with short-term refrigeration for vials in use.

Once reconstituted in bacteriostatic water, keep the solution refrigerated, avoid repeated freezeโ€“thaw cycles and agitation, and label the vial with the reconstitution date and concentration. Discard any solution that turns cloudy or shows particulates.

Degradation rates differ by sequence: peptides containing methionine, cysteine, asparagine or glutamine are more prone to oxidation and deamidation, so shelf life after reconstitution is compound-specific rather than universal.

Read the full guide: how to store peptides before and after reconstitution โ†’

Source: Manning MC, Chou DK, Murphy BM, Payne RW, Katayama DS. Stability of protein pharmaceuticals: an update. Pharm Res. 2010;27(4):544โ€“575. (PMID 20143256). General guidance for research handling; not product-specific instructions.

GHRP-1: frequently asked questions

What is GHRP-1?

Synthetic hexapeptide growth hormone secretagogue from the same series as GHRP-2 and GHRP-6. Not FDA-approved and less studied than either. Human pharmacokinetic data is limited.

How does GHRP-1 work?

GHRP-1 is a synthetic enkephalin-derived peptide that binds the growth hormone secretagogue receptor 1a on pituitary somatotrophs and hypothalamic neurons, the receptor for ghrelin. Activation stimulates pulsatile growth hormone release through a pathway distinct from and synergistic with growth hormone-releasing hormone.

Is GHRP-1 FDA approved?

No. GHRP-1 is not approved by the FDA for any indication and is categorised as research-only. It has not been reviewed for safety or efficacy as a medicine, and published research should be read as investigation rather than established use.

What peptides are similar to GHRP-1?

Compounds most often compared with GHRP-1 include Ipamorelin, GHRP-6, Pralmorelin (GHRP-2) and Hexarelin (Examorelin). They are grouped by shared mechanism or research area rather than by equivalence, and their regulatory status and evidence base differ.

References

Related research, comparisons & guides

Related peptides

Compiled by Peptide Library Editorial ยท Reviewed Aug 30, 2026 ยท Updated Aug 30, 2026 ยท Version 2

This GHRP-1 profile is compiled from published literature (5 cited studies linked above), public regulatory records and chemical registries. It describes what research reports; it is not medical advice, and nothing here is a dosing recommendation for humans. Peptide Library does not sell peptides. Editorial policy ยท How profiles are compiled ยท Report an error

Track GHRP-1 research, inventory and reconstitution in the free Peptide Library app. Get the app for iOS or Android โ†’